IgE generation and mast cell activation

European Journal of Inflammation

Volumn 12, Issue 1, 2014, Pages 21-25

  Kritas, S K ^a   Caraffa, A ^b   Antinolfi, P ^b   Saggini, A ^c   Pantalone, A ^d   Neri, G ^d   Rosati, M ^e   Tei, M ^f   Speziali, A ^f   Saggini, R ^d   Pandolfi, F ^g   Cerulli, G ^f   Conti, P ^d  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e Pescara Hospital   (Italy)

^f Nicola's Foundation   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

Author keywords

B cells; IgE; Inflammation; Mast cells

Indexed keywords

ALPHA INTERFERON; B LYMPHOCYTE ANTIGEN; CD23 ANTIGEN; CD40 LIGAND; CHEMOKINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FC RECEPTOR; GAMMA INTERFERON; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE RELEASE INHIBITOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OMALIZUMAB; PRE B CELL RECEPTOR; PROSTAGLANDIN D2; PROTEIN TYROSINE KINASE INHIBITOR; SYNDECAN 1; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ALLERGIC DISEASE; ALLERGY; ANAPHYLAXIS; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ATOPIC DERMATITIS; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BASOPHIL; BINDING AFFINITY; CELL ACTIVATION; CELL SURVIVAL; CYTOKINE PRODUCTION; EOSINOPHIL; GENE REARRANGEMENT; HORMONE ACTION; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; IMMUNOTHERAPY; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; PROTEIN BINDING; PROTEIN CLEAVAGE; REVIEW; T LYMPHOCYTE; TH17 CELL; TH2 CELL;

EID: 84899099442     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1401200103     Document Type: Review

References (24)

1. Poe JC, Tedder TF. CD22 and Siglec-G in B cell function and tolerance. Trends Immunol 2012; 33(8):413-20.
2. Conticello SG, Langlois MA, Yang Z, Neuberger MS.DNA deamination in immunity: AID in the context of its APOBEC relatives. Adv Immunol 2007; 94:37-73. (Pubitemid 46856607)
3. Kleinnijenhuis J, Quintin J, Preijers F, et al. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun 2014; 6(2):152-8.
4. Cerutti A, Cols M, Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 2013; 13(2):118-32.
5. Deenick EK, Avery DT, Chan A, et al. Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells. J Exp Med 2013; 210(12):2739-53.
6. Smurthwaite L, Durham SR. Local IgE synthesis in allergic rhinitis and asthma. Curr Allergy Asthma Rep 2002; 2(3):231-8.
7. Cerutti A, Puga I, Cols M. New helping friends for B cells. Eur J Immunol 2012; 42(8):1956-68.
8. Aberle N, Gagro A, Rabatic S, Reiner-Banovac Z, Dekaris D. Expression of CD23 antigen and its ligands in children with intrinsic and extrinsic asthma. Allergy 1997; 52(12):1238-42. (Pubitemid 28027041)
9. Eckl-Dorna J, Niederberger V. What is the source of serum allergen-specific IgE? Curr Allergy Asthma Rep 2013; 13(3):281-7.
10. Kurasawa K, Iwamoto I. Mechanism and regulation of IgE production in allergy. Nihon Rinsho 1996; 54(2):434-9.
11. Romagnani S. Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 1994; 6(6):838-46.
12. Tailor P, Tamura T, Kong HJ, Kubota T, Kubota M, Borghi P, Gabriele L, Ozato K. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 2007; 27(2):228-39. (Pubitemid 47284921)
13. Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 2007; 217:65-78. (Pubitemid 46718152)
14. de Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 1998; 102(2):165-9.
15. Hong GU, Kim NG, Jeoung D, Ro JY. Anti-CD40 Ab- or 8-oxo-dG-enhanced Treg cells reduce development of experimental autoimmune encephalomyelitis via down-regulating migration and activation of mast cells. J Neuroimmunol 2013; 260(1-2):60-73.
16. Zhang Y, Lu L, Furlonger C, Wu GE, Paige CJ. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat Immunol 2000; 1(5):392-7.
17. Morteau O, Lu B, Gerard C, Gerard NP. Hemokinin 1 is a full agonist at the substance P receptor. Nat Immunol 2001; 2(12):1088. (Pubitemid 33130136)
18. Lalani I, Bhol K, Ahmed AR. Interleukin-10: biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol 1997; 79(6):469-83.
19. Kritas SK, Saggini A, Varvara G, et al. Impact of mast cells on the skin. Int J Immunopathol Pharmacol 2013; 26(4):855-9.
20. Komai-Koma M, Brombacher F, Pushparaj PN, et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naive mice. Allergy 2012; 67(9):1118-26.
21. Theoharides TC, Zhang B, Kempuraj D, et al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci USA 2010; 107(9):4448-53.
22. Ledermann F, Heusser C, Schlienger C, Le Gros G. Interleukin-3-treated non-B, non-T cells switch activated B cells to IgG1/IgE synthesis. Eur J Immunol 1992; 22(11):2783-7.
23. Mwinzi PN, Ganley-Leal L, Black CL, Secor WE, Karanja DM, Colley DG. Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments. J Infect Dis 2009; 199(2):272-9.
24. Vashisht P, Casale T. Omalizumab for treatment of allergic rhinitis. Expert Opin Biol Ther 2013; 13(6):933-45.